Amneal Pharmaceuticals has agreed to acquire biopharma firm Kashiv BioSciences in a cash-and-stock deal ​worth up to $1.1 billion that will expand ‌the drugmaker's biosimilars business.

Some researchers are delighted at an executive order to streamline investigations of psychedelics but also warn that caution ...

President Trump's executive order is giving psychedelic stocks a boost. These companies are leaders in the industry.

A Lehigh County commissioner has been arrested and is facing drug charges. Commissioner Zachary Cole-Borghi, of Bethlehem, was taken into custody Thursday afternoon at his office inside Bethlehem City ...

President Trump's new executive order has drawn major attention to psychedelic treatments for mental health. Here's what ...

A booming online marketplace exists for alternatives to popular weight-loss medications. But these drugs can be risky.

President Trump has signed an executive order to make certain psychedelic drugs more available to treat mental health ...

The Criterion Collection started out in the 1980s as a simple distribution company. Over the years, the brand has expanded its scope, earning itself icon status among cinephiles for preserving ...

Abivax's leading candidate looks very promising. However, between potential clinical setbacks and the biotech's high market cap, the stock looks risky. That said, with an upcoming catalyst and a ...

Selecting the right AI strategy is critical to delivering accurate, timely, and impactful insights across drug discovery. With rapidly advancing technologies in foundation models, generative AI, and ...

Neurocrine Biosciences NBIX3.19%increase; green up pointing triangle agreed to buy Soleno Therapeutics SLNO-0.01%decrease; red down pointing triangle for $2.9 billion, giving it the first approved ...